You are here: Home » Government Press Release » News
Business Standard

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in Cancer patients: Shri Shripad Yesso Naik

Delhi 

Coded formulation AYUSH-QOL-2C developed to minimize side effects of Chemo and radiotherapy in patients: Shri Shripad Yesso Naik

The Central Council for Research in Ayurvedic Sciences (CCRAS) has developed an anti-diabetic drug AYUSH-82. License has been granted to eight firms through National Research Development Corporation (NRDC) for commercialization.

CCRAS has developed a coded formulation AYUSH-QOL-2C to minimize side effects of Chemo and radiotherapy to improve quality of life in patients. The Central Council for Research in Homoeopathy (CCRH) has undertaken study to assess usefulness of Homoeopathic medicine in patients having side effects from Chemotherapy. The Central Council for Research in Yoga and Naturopathy (CCRYN) organises Yoga and Diabetes awareness programme through Government and Non-Government organizations.

This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Rajya Sabha today.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU